Global and United States Autogenous Vaccines Market Insights, Forecast to 2027

Global and United States Autogenous Vaccines Market Insights, Forecast to 2027

  • QYResearch
  • September 2021
  • Pharmaceutical
  • 153 pages

Report Description

Autogenous vaccines, also called autologous vaccines, autovaccines, self or custom vaccines, are vaccines, which prepared by isolation and destruction of microorganisms in infected individuals and used to provide immunity to the same individual. Generally, indications of autogenous vaccines include resistance of pathogenic microorganisms to antibiotic treatment, ineffective therapy or immune response and lack of commercial vaccines.
Global Autogenous Vaccines key players include Boehringer Ingelheim, Vaxxinova, Zoetis, Ceva Biovac, Phibro, etc. Global top five manufacturers hold a share over 50%. America is the largest market, with a share about 45%, followed by Europe and Asia Pacific, total have a share over 50 percent. In terms of product, Poultry is the largest segment, with a share over 50%. And in terms of application, the largest application is Large Farms, followed by Small Farms.

Market Analysis and Insights: Global and United States Autogenous Vaccines Market
This report focuses on global and United States Autogenous Vaccines market.
In 2020, the global Autogenous Vaccines market size was US$ 413 million and it is expected to reach US$ 560.6 million by the end of 2027, with a CAGR of 4.4% during 2021-2027. In United States the Autogenous Vaccines market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Autogenous Vaccines Scope and Market Size
Autogenous Vaccines market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Autogenous Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Autogenous Vaccines market size by players, by Obejection, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Obejection
Poultry
Fishes
Pigs & Cattle
Other

Segment by Application
Large Farms
Small Farms

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Boehringer Ingelheim
Vaxxinova
Zoetis
Ceva Biovac
Phibro
Elanco
AniCon Labor GmbH
Cambridge Technologies
AVICARE plus
Genova Labs
Addison Biological Laboratory
ACE Laboratory Services
Deltamune
Dyntec
Hygieia Biological Laboratories

Have query on this report?

Make an Enquiry
1 Study Coverage
1.1 Autogenous Vaccines Product Introduction
1.2 Market by Obejection
1.2.1 Global Autogenous Vaccines Market Size Growth Rate by Obejection
1.2.2 Poultry
List of Tables
Table 1. Global Autogenous Vaccines Market Size Growth Rate by Obejection, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Poultry
Table 3. Major Manufacturers of Fishes
Table 4. Major Manufacturers of Pigs & Cattle
Table 5. Major Manufacturers of Other

Success Stories

Our Clients